Have you seen the news about FLAURA2? TAGRISSO (osimertinib) is now approved for a new indication! To learn more about the newest approval, please click the link below or visit the TAGRISSO HCP Website.
This content is sponsored by AstraZeneca, and ION Oncology Practice Network has not independently reviewed or verified the information provided by AstraZeneca.
This email was sent to madeleine.dillon@cencora.com because you have an account with or are a valued partner of ION Oncology Practice Network. If you no longer wish to receive these types of emails, please click here to unsubscribe or update your email preferences.
